Navigation Links
State of Cancer Care for Nation's Poor and Minorities Is Focus of Conference in Washington
Date:3/28/2008

Forum Is Largest Meeting on Disparities in Cancer Care and Survival

WASHINGTON, March 28 /PRNewswire-USNewswire/ -- The state of cancer care for the nation's poor and ethnic minorities will be addressed when the Intercultural Cancer Council (ICC) and Baylor College of Medicine hold the 11th Biennial Symposium on Minorities, The Medically Underserved & Cancer April 3-6 at the Omni Shoreham Hotel in Washington, DC.

The ICC Biennial Symposium is the largest forum in the United States and its associated territories solely designed to confront the disproportionately greater suffering and compromised health from cancer facing the medically underserved, such as racial and ethnic minorities. The conference will feature more than 40 educational sessions, an information exchange forum, and several awards ceremonies, including one to honor Maureen Lichtveld, M.D., M.P.H., a pioneer in the science of gene-environment interaction, especially as it relates to environmentally induced carcinogenesis.

With the theme Charting a New Course Together: Quality Health Care for All, ICC's 11th biennial symposium comes at a time when new reports document disproportionate rates of the incidence, prevalence, mortality, survival, risks and treatment of cancer for racial and ethnic minorities and those living in rural areas. A major topic on the agenda will be mobilizing communities to overcome these disparities by learning about innovative programs to increase cancer screenings and to recruit more cancer patients into clinical trials at the local level. The forum will also focus on best practices in patient navigation for those undergoing cancer treatment and increased access to pain management and palliative care at the end of life, areas where disparities in cancer care are significant.

"As a nation, we have witnessed significant declines in cancer deaths, but not all Americans are benefiting equally from this progress. Cancer is an area where racia
'/>"/>

SOURCE Intercultural Cancer Council
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Statement in Response to SEIU United Healthcare Workers - Wests (UHW-W) Thursday Media Event
2. Radian Guaranty Inc. Eliminates Stated Income and Stated Asset Programs
3. CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders Equity
4. Mens Health Policy Center Hosts Petition to Protest Government Barrier to Prostate Cancer Medications
5. National, State Front Line Caregivers Warn About $64 Million Cut to Medicare Funding for Care of Michigan Seniors
6. NCPA Statement on Californias Delay of E-Pedigree Implementation
7. AHRQs 2007 State Snapshots Provide Broader Portraits of State-By-State Health Care Performance
8. American Academy of Dermatology Issues Statement Urging the Public to be Sun Smart(SM)
9. State of Alaska and Eli Lilly and Company Reach Agreement to Settle Zyprexa Lawsuit
10. SCI Real Estate Investments Joins City of Hope to Fight Cancer
11. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 1New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 2New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 4New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 5New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 6New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 7New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 8New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 9New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 10New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 11New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 12New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 13New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 14New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 15New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 16New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 17New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 18New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 19New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 20New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 21New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 22Hologic Expands Healthcare Investment in Asia 5563 1Hologic Expands Healthcare Investment in Asia 5563 2Hologic Expands Healthcare Investment in Asia 5563 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2